Gregory Braden to Follow-Up Studies
This is a "connection" page, showing publications Gregory Braden has written about Follow-Up Studies.
Connection Strength
0.094
-
Braden GL, Germain MJ, Mulhern JG, Hafer JG, Bria WF. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients. Chest. 1998 Aug; 114(2):380-7.
Score: 0.026
-
Freda BJ, Knee AB, Braden GL, Visintainer PF, Thakar CV. Effect of Transient and Sustained Acute Kidney Injury on Readmissions in Acute Decompensated Heart Failure. Am J Cardiol. 2017 06 01; 119(11):1809-1814.
Score: 0.024
-
Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR, Kusek JW, Feldman HI. Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol. 2011 Apr; 22(4):773-81.
Score: 0.016
-
Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou TM, DiDonato K. The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study. Catheter Cardiovasc Interv. 2006 Nov; 68(5):684-9.
Score: 0.012
-
Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005 Feb; 45(2):281-7.
Score: 0.010
-
Lipkowitz GS, Madden RL, Mulhern J, Braden G, O'Shea M, O'Shaughnessy J, Nash S, Kurbanov A, Freeman J, Rennke H, Germain M. Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity. Transpl Int. 1999; 12(3):202-7.
Score: 0.007